Back to search
Mesothelin-positive Advanced Malignant Solid Tumors
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Mesothelin-positive Advanced Malignant Solid Tumors trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Mesothelin-positive Advanced Malignant Solid Tumors trials you may qualify forThis is a Phase 1a/1b open-label, dose escalation study to evaluate the safety and efficacy of CT-95 (study drug), a humanized T cell engaging bispecific antibo…
This is a single-arm, open-label, exploratory clinical study to evaluate the safety, tolerability and preliminary efficacy of Anti-Mesothelin CAR-T cell injecti…
This is a first-in-human, single-arm, open-label, dose escalation clinical study to evaluate the safety, tolerability, pharmacokinetic and pharmacodynamic chara…
This is a single-arm, open-label, exploratory clinical study to evaluate the safety, tolerability and preliminary efficacy of UCLM802 (Anti-Mesothelin CAR-T) ce…
This study aims to explore the safety, tolerability and preliminary efficacy of Anti-Mesothelin CAR-T cells in subjects with Mesothelin-positive advanced malign…